Product Code: BHL1258SA
“Global Pharmaceutical Aseptic Transfer Market to Reach $2,551.5 Million by 2031.”
Global Pharmaceutical Aseptic Transfer Market Industry Overview
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031. The growth in the global pharmaceutical aseptic transfer market is expected to be driven by the rapid expansion of the pharmaceutical industry, the significant rise of investment in the pharmaceutical industry, the implementation of stringent regulations for drug approval processes, and the growing demand for automated products for aseptic transfer processes.
Market Lifecycle Stage
The pharmaceutical aseptic transfer market is in the developed phase. The increasing demand for single-use aseptic transfer systems, increasing demand for liquid aseptic transfer systems, and the integration of Industry 4.0 within the pharmaceutical aseptic industry are some of the major opportunities in the global pharmaceutical aseptic transfer market. Furthermore, some of the key trends going on in the market are the shift from conventional cleanroom technology to barrier technology, the development of single-use transfer solutions, the rising demand for genderless aseptic connectors, and the increasing number of mergers and acquisitions (M&As) among market players.
Impact of COVID-19
The COVID-19 pandemic led to pharmaceutical companies investing heavily in R&D and ramping up production of potentially life-saving drugs for COVID-19. The unprecedented demand for these drugs and the urgency to cater to the demand within a short span of time led to higher demand for the maintenance of an aseptic environment in order to ensure regulatory compliance and faster time-to-market. However, the trade and travel restrictions amidst the COVID-19 pandemic placed a higher burden on the supply chain, with the procurement of components and systems becoming more challenging.
Overall, while the supply side was negatively impacted, especially during the peak of the COVID-19 pandemic, the significantly high demand for aseptic solutions offset the negative impact and led to positive growth of the market in 2020 and 2021.
Market Segmentation:
Segmentation 1: by System Type
- Liquid Transfer System
- Solid Transfer System
The global pharmaceutical aseptic transfer market (by system type) is expected to be dominated by the solid transfer system segment.
Segmentation 2: by Usability
The global pharmaceutical aseptic transfer market (by usability) is dominated by the multiple-use segment.
Segmentation 3: by Transfer Type
The global pharmaceutical aseptic transfer market (by transfer type) is dominated by the others segment.
Segmentation 4: by End User
- Contract Development and Manufacturing Organizations (CDMOs)
The global pharmaceutical aseptic transfer market (by end user) is dominated by the pharmaceutical companies segment.
Segmentation 5: by Region
- North America - U.S., Canada
- Europe - Germany, France, U.K., Italy, Spain, Rest-of-Europe
- Asia-Pacific - Japan, China, India, Australia, South Korea, Rest-of-Asia-Pacific
- Latin America - Brazil, Mexico, Rest-of-Latin America
- Middle East and Africa - U.A.E., South Africa, Rest-of-Middle East and Africa
Recent Developments in Global Pharmaceutical Aseptic Transfer Market
- In June 2022, ChargePoint Technology acquired a single-use product and accessory manufacturer, Terracon.
- In January 2022, ChargePoint Technology accelerated expansion to enhance services in the U.S. market.
- In June 2022, Getinge AB launched its DPTE-EXO with sleeveless DPTE-BetaBag. This alpha port ensures automated aseptic transfer and assists in enhancing operational proficiency.
- In November 2021, Getinge AB extended its presence in Vietnam by forming its legitimate unit, Getinge Vietnam.
- In November 2021, Sartorius AG expanded its production capacities in France for storage and further innovation to meet the rising demands of the pharmaceutical industry.
- In September 2021, Sartorius AG expanded its manufacturing facilities in China in biological drug discovery, process development, testing, and validation to meet growing local customer demand.
- In March 2021, Arcline Investment Management acquired ChargePoint Technology to fuel an increased global presence.
- In January 2021, Getinge AB expanded the production capacity of its DPTE BetaBags in the U.S. by establishing the manufacturing of these BetaBags at its site in Merrimack, New Hampshire.
- In December 2020, Pall Corporation established a strategic partnership with Single Use Support GmbH to distribute the RoSS SHELL platform of the company globally.
- In June 2020, ABS Transfer SAS raised $3.2 million (€3 million), in the series A funding round led by Go Capital, along with Bpifrance and the regional government of Centre-Val de Loire.
Demand - Drivers and Limitations
Following are the drivers for the global pharmaceutical aseptic transfer market:
- Rapid Expansion of the Pharmaceutical Industry
- Significant Rise of Investment in the Pharmaceutical Industry
- Implementation of Stringent Regulations for Drug Approval Processes
- Growing Demand for Automated Products for Aseptic Transfer Processes
The market is expected to face some limitations too due to the following challenges:
- Complex Development Cycle of Aseptic Transfer Systems and Requirement of Large Capital Investment for Installation
- Lack of Skilled Personnel
- Growing Preference for Refurbished Equipment
How can this report add value to an organization?
- Product/Innovation Strategy: The product segment helps the reader understand the different types of aseptic transfer products and accessories available for use in the pharmaceutical industry. Moreover, the study provides the reader with a detailed understanding of the different aseptic transfer products by system type (liquid transfer system and solid transfer system), usability (single-use and multiple-use), transfer type (ports, portbags, and others), and end user (pharmaceutical companies, contract development manufacturing organizations (CDMOs), and others).
- Growth/Marketing Strategy: The global pharmaceutical aseptic transfer market has seen major development by key players operating in the market, such as business expansion, partnership, collaborations and business expansions, mergers and acquisitions, product launches, and funding activities. The favored strategy for the companies has been partnerships, alliances, and business expansions to strengthen their position in the global pharmaceutical aseptic transfer market. For instance, in June 2022, Tema Sinergie and AMERICAN FARMAGRUP S.A.S partnered to provide customized solutions for the pharmaceutical industry in South America.
- Competitive Strategy: Key players in the global pharmaceutical aseptic transfer market analyzed and profiled in the study involve players that offer aseptic transfer products and services. Moreover, a detailed market share analysis of the players operating in the global pharmaceutical aseptic transfer market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the prominent established names in this market are:
- ABC Transfer SAS
- ATS Automation Tooling Systems, Inc.
- Azbil Corporation
- Castus GmbH & Co. KG
- ChargePoint Technology
- Dover Corporation
- EnPro Industries, Inc.
- Entegris Inc.
|
- Ezi-Dock Systems Ltd.
- Getinge AB
- ILC Dover LP
- JCE Biotechnology
- Rommelag
- Sartorius AG
- Single Use Support GmbH
|
Table of Contents
1 Markets
- 1.1 Global Market Outlook
- 1.1.1 Product Definition
- 1.1.2 Inclusion and Exclusion Criteria
- 1.1.3 Key Findings
- 1.1.4 Assumptions and Limitations
- 1.1.5 Global Market Scenario
- 1.1.5.1 Realistic Growth Scenario
- 1.1.5.2 Optimistic Growth Scenario
- 1.1.5.3 Pessimistic/Conservative Growth Scenario
- 1.2 Industry Outlook
- 1.2.1 Key Trends
- 1.2.1.1 Shift from Conventional Cleanroom Technology to Barrier Technology
- 1.2.1.2 Development of Single-Use Transfer Solutions
- 1.2.1.3 Rising Demand for Genderless Aseptic Connectors
- 1.2.1.4 Use of Robotics in Aseptic Processes
- 1.2.1.5 Increasing Number of Mergers and Acquisitions (M&As)
- 1.2.2 Opportunity Assessment
- 1.2.3 Patent Analysis
- 1.2.3.1 Patent Filing Trend (by Country/Cluster)
- 1.2.3.2 Patent Filing Trend (by Year)
- 1.2.4 Product Benchmarking
- 1.2.5 Distributor Analysis
- 1.2.6 Case Studies
- 1.2.6.1 Case Study 1: North American CDMO selects ChargePoint Technology for Sterile API Transfer
- 1.2.6.2 Case Study 2: Central Research Laboratories Offering Single-Use Products with Multiple Benefits
- 1.3 Impact of COVID-19 on the Global Pharmaceutical Aseptic Transfer Market
- 1.3.1 Impact on Adoption of Aseptic Transfer Solutions
- 1.3.2 Impact on Market Size
- 1.3.2.1 Pre-COVID-19 Phase
- 1.3.2.2 During-COVID-19 Phase
- 1.3.2.3 Post-COVID-19 Phase
- 1.3.3 Market Entry Barriers and Opportunities
- 1.4 Business Dynamics
- 1.4.1 Impact Analysis
- 1.4.2 Business Drivers
- 1.4.2.1 Rapid Expansion of the Pharmaceutical Industry
- 1.4.2.2 Significant Rise of Investment in the Pharmaceutical Industry
- 1.4.2.3 Implementation of Stringent Regulations for Drug Approval Processes
- 1.4.2.4 Growing Demand for Automated Products for Aseptic Transfer Processes
- 1.4.3 Business Restraints
- 1.4.3.1 Complex Development Cycle of Aseptic Transfer Systems and Requirement of Large Capital Investment for Installation
- 1.4.3.2 Lack of Skilled Personnel
- 1.4.3.3 Growing Preference for Refurbished Equipment
- 1.4.4 Business Opportunities
- 1.4.4.1 Increasing Demand for Single-Use Aseptic Transfer Systems
- 1.4.4.2 Liquid Aseptic Transfer Systems Gaining Traction
- 1.4.4.3 Integration of Industry 4.0 within the Pharmaceutical Aseptic Industry
- 1.5 Trends among Stakeholders: Pharmaceutical Companies and CDMOs
2 Global Pharmaceutical Aseptic Transfer Market (by Usability)
- 2.1 Opportunity Assessment
- 2.2 Growth-Share Matrix
- 2.3 Single-Use
- 2.4 Multiple-Use
3 Global Pharmaceutical Aseptic Transfer Market (by System Type)
- 3.1 Opportunity Assessment
- 3.2 Growth-Share Matrix
- 3.3 Solid Transfer System
- 3.4 Liquid Transfer System
4 Global Pharmaceutical Aseptic Transfer Market (by End User)
- 4.1 Opportunity Assessment
- 4.2 Growth-Share Matrix
- 4.3 Pharmaceutical Companies
- 4.4 Contract Development and Manufacturing Organizations (CDMOs)
- 4.5 Others
5 Global Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 5.1 Opportunity Assessment
- 5.2 Growth-Share Matrix
- 5.3 Ports
- 5.4 Portbags
- 5.5 Others
6 Region
- 6.1 North America
- 6.1.1 Key Findings and Opportunity Assessment
- 6.1.2 Regulatory Framework
- 6.1.3 Market Dynamics
- 6.1.4 Market Sizing and Forecast
- 6.1.4.1 North America Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.1.4.2 North America Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.1.4.3 North America Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.1.4.4 North America Pharmaceutical Aseptic Transfer Market (by End User)
- 6.1.4.5 North America Pharmaceutical Aseptic Transfer Market (by Country)
- 6.1.4.5.1 U.S.
- 6.1.4.5.1.1 Market Dynamics
- 6.1.4.5.1.2 Market Sizing and Forecast
- 6.1.4.5.1.2.1 U.S. Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.1.4.5.1.2.2 U.S. Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.1.4.5.1.2.3 U.S. Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.1.4.5.1.2.4 U.S. Pharmaceutical Aseptic Transfer Market (by End User)
- 6.1.4.5.2 Canada
- 6.1.4.5.2.1 Market Dynamics
- 6.1.4.5.2.2 Market Sizing and Forecast
- 6.1.4.5.2.2.1 Canada Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.1.4.5.2.2.2 Canada Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.1.4.5.2.2.3 Canada Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.1.4.5.2.2.4 Canada Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2 Europe
- 6.2.1 Key Findings and Opportunity Assessment
- 6.2.2 Regulatory Framework
- 6.2.3 Market Dynamics
- 6.2.4 Market Sizing and Forecast
- 6.2.4.1 Europe Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.2 Europe Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.3 Europe Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.4 Europe Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2.4.5 Europe Pharmaceutical Aseptic Transfer Market (by Country)
- 6.2.4.5.1 Germany
- 6.2.4.5.1.1 Market Dynamics
- 6.2.4.5.1.2 Market Sizing and Forecast
- 6.2.4.5.1.2.1 Germany Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.5.1.2.2 Germany Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.5.1.2.3 Germany Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.5.1.2.4 Germany Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2.4.5.2 U.K.
- 6.2.4.5.2.1 Market Dynamics
- 6.2.4.5.2.2 Market Sizing and Forecast
- 6.2.4.5.2.2.1 U.K. Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.5.2.2.2 U.K. Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.5.2.2.3 U.K. Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.5.2.2.4 U.K. Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2.4.5.3 France
- 6.2.4.5.3.1 Market Dynamics
- 6.2.4.5.3.2 Market Sizing and Forecast
- 6.2.4.5.3.2.1 France Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.5.3.2.2 France Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.5.3.2.3 France Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.5.3.2.4 France Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2.4.5.4 Italy
- 6.2.4.5.4.1 Market Dynamics
- 6.2.4.5.4.2 Market Sizing and Forecast
- 6.2.4.5.4.2.1 Italy Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.5.4.2.2 Italy Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.5.4.2.3 Italy Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.5.4.2.4 Italy Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2.4.5.5 Spain
- 6.2.4.5.5.1 Market Dynamics
- 6.2.4.5.5.2 Market Sizing and Forecast
- 6.2.4.5.5.2.1 Spain Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.5.5.2.2 Spain Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.5.5.2.3 Spain Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.5.5.2.4 Spain Pharmaceutical Aseptic Transfer Market (by End User)
- 6.2.4.5.6 Rest-of-Europe
- 6.2.4.5.6.1 Market Dynamics
- 6.2.4.5.6.2 Market Sizing and Forecast
- 6.2.4.5.6.2.1 Rest-of-Europe Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.2.4.5.6.2.2 Rest-of-Europe Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.2.4.5.6.2.3 Rest-of-Europe Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.2.4.5.6.2.4 Rest-of-Europe Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3 Asia-Pacific
- 6.3.1 Key Findings and Opportunity Assessment
- 6.3.2 Regulatory Framework
- 6.3.3 Market Dynamics
- 6.3.4 Market Sizing and Forecast
- 6.3.4.1 Asia-Pacific Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.2 Asia-Pacific Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.3 Asia-Pacific Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.4 Asia-Pacific Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3.4.5 Asia-Pacific Pharmaceutical Aseptic Transfer Market (by Country)
- 6.3.4.5.1 Japan
- 6.3.4.5.1.1 Market Dynamics
- 6.3.4.5.1.2 Market Sizing and Forecast
- 6.3.4.5.1.2.1 Japan Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.5.1.2.2 Japan Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.5.1.2.3 Japan Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.5.1.2.4 Japan Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3.4.5.2 China
- 6.3.4.5.2.1 Market Dynamics
- 6.3.4.5.2.2 Market Sizing and Forecast
- 6.3.4.5.2.2.1 China Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.5.2.2.2 China Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.5.2.2.3 China Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.5.2.2.4 China Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3.4.5.3 India
- 6.3.4.5.3.1 Market Dynamics
- 6.3.4.5.3.2 Market Sizing and Forecast
- 6.3.4.5.3.2.1 India Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.5.3.2.2 India Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.5.3.2.3 India Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.5.3.2.4 India Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3.4.5.4 South Korea
- 6.3.4.5.4.1 Market Dynamics
- 6.3.4.5.4.2 Market Sizing and Forecast
- 6.3.4.5.4.2.1 South Korea Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.5.4.2.2 South Korea Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.5.4.2.3 South Korea Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.5.4.2.4 South Korea Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3.4.5.5 Australia
- 6.3.4.5.5.1 Market Dynamics
- 6.3.4.5.5.2 Market Sizing and Forecast
- 6.3.4.5.5.2.1 Australia Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.5.5.2.2 Australia Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.5.5.2.3 Australia Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.5.5.2.4 Australia Pharmaceutical Aseptic Transfer Market (by End User)
- 6.3.4.5.6 Rest-of-Asia-Pacific
- 6.3.4.5.6.1 Market Dynamics
- 6.3.4.5.6.2 Market Sizing and Forecast
- 6.3.4.5.6.2.1 Rest-of-Asia-Pacific Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.3.4.5.6.2.2 Rest-of-Asia-Pacific Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.3.4.5.6.2.3 Rest-of-Asia-Pacific Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.3.4.5.6.2.4 Rest-of-Asia-Pacific Pharmaceutical Aseptic Transfer Market (by End User)
- 6.4 Latin America
- 6.4.1 Key Findings and Opportunity Assessment
- 6.4.2 Regulatory Framework
- 6.4.3 Market Dynamics
- 6.4.4 Market Sizing and Forecast
- 6.4.4.1 Latin America Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.4.4.2 Latin America Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.4.4.3 Latin America Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.4.4.4 Latin America Pharmaceutical Aseptic Transfer Market (by End User)
- 6.4.4.5 Latin America Pharmaceutical Aseptic Transfer Market (by Country)
- 6.4.4.5.1 Brazil
- 6.4.4.5.1.1 Market Dynamics
- 6.4.4.5.1.2 Market Sizing and Forecast
- 6.4.4.5.1.2.1 Brazil Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.4.4.5.1.2.2 Brazil Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.4.4.5.1.2.3 Brazil Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.4.4.5.1.2.4 Brazil Pharmaceutical Aseptic Transfer Market (by End User)
- 6.4.4.5.2 Mexico
- 6.4.4.5.2.1 Market Dynamics
- 6.4.4.5.2.2 Market Sizing and Forecast
- 6.4.4.5.2.2.1 Mexico Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.4.4.5.2.2.2 Mexico Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.4.4.5.2.2.3 Mexico Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.4.4.5.2.2.4 Mexico Pharmaceutical Aseptic Transfer Market (by End User)
- 6.4.4.6 Rest-of-Latin America
- 6.4.4.6.1 Market Dynamics
- 6.4.4.6.2 Market Sizing and Forecast
- 6.4.4.6.2.1 Rest-of-Latin America Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.4.4.6.2.2 Rest-of-Latin America Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.4.4.6.2.3 Rest-of-Latin America Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.4.4.6.2.4 Rest-of-Latin America Pharmaceutical Aseptic Transfer Market (by End User)
- 6.5 Middle East and Africa
- 6.5.1 Key Findings and Opportunity Assessment
- 6.5.2 Regulatory Framework
- 6.5.3 Market Dynamics
- 6.5.4 Market Sizing and Forecast
- 6.5.4.1.1 Middle East and Africa Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.5.4.2 Middle East and Africa Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.5.4.3 Middle East and Africa Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.5.4.4 Middle East and Africa Pharmaceutical Aseptic Transfer Market (by End User)
- 6.5.4.5 Middle East and Africa Pharmaceutical Aseptic Transfer Market (by Country)
- 6.5.4.5.1 U.A.E.
- 6.5.4.5.1.1 Market Dynamics
- 6.5.4.5.1.2 Market Sizing and Forecast
- 6.5.4.5.1.2.1 U.A.E. Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.5.4.5.1.2.2 U.A.E. Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.5.4.5.1.2.3 U.A.E. Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.5.4.5.1.2.4 U.A.E. Pharmaceutical Aseptic Transfer Market (by End User)
- 6.5.4.5.2 South Africa
- 6.5.4.5.2.1 Market Dynamics
- 6.5.4.5.2.2 Market Sizing and Forecast
- 6.5.4.5.2.2.1 South Africa Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.5.4.5.2.2.2 South Africa Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.5.4.5.2.2.3 South Africa Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.5.4.5.2.2.4 South Africa Pharmaceutical Aseptic Transfer Market (by End User)
- 6.5.4.5.3 Rest-of-Middle East and Africa
- 6.5.4.5.3.1 Market Dynamics
- 6.5.4.5.3.2 Market Sizing and Forecast
- 6.5.4.5.3.2.1 Rest-of-Middle East and Africa Pharmaceutical Aseptic Transfer Market (by Usability)
- 6.5.4.5.3.2.2 Rest-of-Middle East and Africa Pharmaceutical Aseptic Transfer Market (by System Type)
- 6.5.4.5.3.2.3 Rest-of-Middle East and Africa Pharmaceutical Aseptic Transfer Market (by Transfer Type)
- 6.5.4.5.3.2.4 Rest-of-Middle East and Africa Pharmaceutical Aseptic Transfer Market (by End User)
7 Markets - Competitive Benchmarking & Company Profiles
- 7.1 Competitive Benchmarking and Company Profiles
- 7.1.1 Competitive Landscape
- 7.1.1.1 Key Strategies and Developments
- 7.1.1.1.1 Partnerships, Alliances, and Business Expansions
- 7.1.1.1.2 Mergers and Acquisitions
- 7.1.1.1.3 New Offerings
- 7.1.1.1.4 Funding Activities
- 7.2 Market Share Analysis
- 7.3 Company Profiles
- 7.3.1 ABC Transfer SAS
- 7.3.1.1 Company Overview
- 7.3.1.2 Role of ABC Transfer SAS in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.1.3 Product Portfolio
- 7.3.1.4 Recent Developments
- 7.3.1.5 Target Customers
- 7.3.1.6 Analyst's Perspective
- 7.3.2 ATS Automation Tooling Systems, Inc.
- 7.3.2.1 Company Overview
- 7.3.2.2 Role of ATS Automation Tooling Systems, Inc. in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.2.3 Product Portfolio
- 7.3.2.4 Financials
- 7.3.2.5 Target Customers
- 7.3.2.6 Analyst's Perspective
- 7.3.3 Azbil Corporation
- 7.3.3.1 Company Overview
- 7.3.3.2 Role of Azbil Corporation in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.3.3 Product Portfolio
- 7.3.3.4 Financials
- 7.3.3.5 Target Customers
- 7.3.3.6 Analyst's Perspective
- 7.3.4 Castus GmbH & Co. KG
- 7.3.4.1 Company Overview
- 7.3.4.2 Role of Castus GmbH & Co. KG in Global Pharmaceutical Aseptic Transfer Market
- 7.3.4.3 Product Portfolio
- 7.3.4.4 Recent Developments
- 7.3.4.5 Target Customers
- 7.3.4.6 Analyst's Perspective
- 7.3.5 ChargePoint Technology
- 7.3.5.1 Company Overview
- 7.3.5.2 Role of ChargePoint Technology in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.5.3 Product Portfolio
- 7.3.5.4 Recent Developments
- 7.3.5.5 Target Customers
- 7.3.5.6 Analyst's Perspective
- 7.3.6 Dover Corporation
- 7.3.6.1 Company Overview
- 7.3.6.2 Role of Dover Corporation in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.6.3 Product Portfolio
- 7.3.6.4 Financials
- 7.3.6.5 Target Customers
- 7.3.6.6 Analyst's Perspective
- 7.3.7 EnPro Industries, Inc.
- 7.3.7.1 Company Overview
- 7.3.7.2 Role of EnPro Industries, Inc. in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.7.3 Product Portfolio
- 7.3.7.4 Financials
- 7.3.7.5 Recent Developments
- 7.3.7.6 Target Customers
- 7.3.7.7 Analyst's Perspective
- 7.3.8 Entegris Inc.
- 7.3.8.1 Company Overview
- 7.3.8.2 Role of Entegris Inc. in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.8.3 Product Portfolio
- 7.3.8.4 Financials
- 7.3.8.5 Recent Developments
- 7.3.8.6 Target Customers
- 7.3.8.7 Analyst's Perspective
- 7.3.9 Ezi-Dock Systems Ltd.
- 7.3.9.1 Company Overview
- 7.3.9.2 Role of Ezi-Dock Systems Ltd. in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.9.3 Product Portfolio
- 7.3.9.4 Recent Developments
- 7.3.9.5 Target Customers
- 7.3.9.6 Analyst's Perspective
- 7.3.10 Getinge AB
- 7.3.10.1 Company Overview
- 7.3.10.2 Role of Getinge AB in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.10.3 Product Portfolio
- 7.3.10.4 Financials
- 7.3.10.5 Recent Developments
- 7.3.10.6 Target Customers
- 7.3.10.7 Analyst's Perspective
- 7.3.11 ILC Dover LP
- 7.3.11.1 Company Overview
- 7.3.11.2 Role of ILC Dover LP in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.11.3 Product Portfolio
- 7.3.11.4 Recent Developments
- 7.3.11.5 Target Customers
- 7.3.11.6 Analyst's Perspective
- 7.3.12 JCE Biotechnology
- 7.3.12.1 Company Overview
- 7.3.12.2 Role of JCE Biotechnology in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.12.3 Product Portfolio
- 7.3.12.4 Target Customers
- 7.3.12.5 Analyst's Perspective
- 7.3.13 Rommelag
- 7.3.13.1 Company Overview
- 7.3.13.2 Role of Rommelag in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.13.3 Product Portfolio
- 7.3.13.4 Target Customers
- 7.3.13.5 Analyst's Perspective
- 7.3.14 Sartorius AG
- 7.3.14.1 Company Overview
- 7.3.14.2 Role of Sartorius AG in Global Pharmaceutical Aseptic Transfer Market
- 7.3.14.3 Product Portfolio
- 7.3.14.4 Financials
- 7.3.14.5 Recent Developments
- 7.3.14.6 Target Customers
- 7.3.14.7 Analyst's Perspective
- 7.3.15 Single Use Support GmbH
- 7.3.15.1 Company Overview
- 7.3.15.2 Role of Single Use Support GmbH in the Global Pharmaceutical Aseptic Transfer Market
- 7.3.15.3 Product Portfolio
- 7.3.15.4 Recent Developments
- 7.3.15.5 Target Customers
- 7.3.15.6 Analyst's Perspective